The global Liposomal Amikacin market was valued at US$ 180 million in 2023 and is anticipated to reach US$ 164.6 million by 2030, witnessing a CAGR of -1.3% during the forecast period 2024-2030.
Liposomal Amikacin - Market Size
US$ 164.6 million
Forecasted years
2024 - 2030
Segment by Type
Brands - Generic
Segment by Application
Hospital - Drugs Store
Segment by Application
Hospital - Drugs Store
By Region
- North America (United States, Canada)
- Europe (Germany, France, UK, Italy, Russia) Rest of Europe
- Nordic Countries
- Asia-Pacific (China, Japan, South Korea)
- Southeast Asia (India, Australia)
- Rest of Asia
- Latin America (Mexico, Brazil)
- Rest of Latin America
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
